Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain

Geahča maid

• Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain
  Dahkki: Lisa L. Wilson, et al.
  Almmustuhtton: (2022-06-01)
• Targeting Sigma-1 and Sigma-2 Receptors in Neuropathic Pain: Pharmacology, Ligand Development, and Translational Progress
  Dahkki: Carlo Reale, et al.
  Almmustuhtton: (2026-03-01)
• The spectrum of $\sigma$-frames in the adjunction between $\sigma$-frames and $\sigma$-spaces
  Dahkki: Abolghasem Karimi Feizabadi, et al.
  Almmustuhtton: (2026-07-01)
• Six sigma and six sigma system in the function of quality and profits increase
  Dahkki: Popović Branko, et al.
  Almmustuhtton: (2016-01-01)
• Inhibition of sigma-1 receptor reduces DRG cell apoptosis of rats with neuropathic pain
  Dahkki: YU Dongling, MO Shaoe, FU Wen, CHEN Shi, XIE Chouqin, LAN Yuyan
  Almmustuhtton: (2024-08-01)